CLINICAL_TRIALS
trial_result
· 2016-03-22
Clinical Trial Update: Interleukin (IL)-1 Blockade in Acute Heart Failure (Anakinra ADHF) [Phase 2, Phase 3]
Summary
Phase 2/3 study evaluating interleukin-1 blockade with anakinra in acute heart failure has completed. Trial results were posted in March 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Virginia Commonwealth University | Conditions: Heart Failure | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-03-22